Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double low-dose liver CT with deep-learning contrast boosting in HCC high-risk patients
NCT04722120Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2016
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Randomised, single-blind trial in hepatocellular carcinoma (HCC) (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Detection rate of solid focal lesion in liver at 12 months and Quantitative image quality analysis. Started Jun 2016; status: completed.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT04722120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04722120.